ES2092275T3 - Producto nutritivo para personas que reciben dialisis renal. - Google Patents

Producto nutritivo para personas que reciben dialisis renal.

Info

Publication number
ES2092275T3
ES2092275T3 ES93900015T ES93900015T ES2092275T3 ES 2092275 T3 ES2092275 T3 ES 2092275T3 ES 93900015 T ES93900015 T ES 93900015T ES 93900015 T ES93900015 T ES 93900015T ES 2092275 T3 ES2092275 T3 ES 2092275T3
Authority
ES
Spain
Prior art keywords
people
kidney dialysis
nutritive product
product
receive kidney
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900015T
Other languages
English (en)
Inventor
Rohini Prakash Mulchandani
Judith Ann Gluvna
Tina Maria Knisley
David Benning Cockram
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2092275T3 publication Critical patent/ES2092275T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN PRODUCTO NUTRITIVO LIQUIDO SE FORMULA ESPECIALMENTE PARA SATISFACER LAS NECESIDADES DE UNA PERSONA QUE RECIBE DIALISIS RENAL. LA DISTRIBUCION CALORICA, VITAMINAS Y MINERALES, Y ELECTROLITOS SE CONTROLAN CUIDADOSAMENTE. LA FUENTE DE MAGNESIO EN EL PRODUCTO ES UN CASEINATO DE MAGNESIO CALCICO.
ES93900015T 1991-06-10 1992-05-07 Producto nutritivo para personas que reciben dialisis renal. Expired - Lifetime ES2092275T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/712,768 US5108767A (en) 1991-06-10 1991-06-10 Liquid nutritional product for persons receiving renal dialysis

Publications (1)

Publication Number Publication Date
ES2092275T3 true ES2092275T3 (es) 1996-11-16

Family

ID=24863485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900015T Expired - Lifetime ES2092275T3 (es) 1991-06-10 1992-05-07 Producto nutritivo para personas que reciben dialisis renal.

Country Status (10)

Country Link
US (1) US5108767A (es)
EP (1) EP0587824B1 (es)
AU (1) AU659188B2 (es)
CA (1) CA2099880C (es)
DE (1) DE69212316T2 (es)
DK (1) DK0587824T3 (es)
ES (1) ES2092275T3 (es)
HK (1) HK1004513A1 (es)
MX (1) MX9202744A (es)
WO (1) WO1992022218A1 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100095A (en) * 1991-04-08 2000-08-08 The Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
US5460972A (en) 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
JP2702322B2 (ja) * 1991-08-08 1998-01-21 フジックス株式会社 活性アミノ酸カルシウム、およびそれを含有する飲料、ならびにその製造方法
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.
WO1994003215A1 (en) * 1992-07-30 1994-02-17 Andrew Stone Dialysis system, method and filtrate solution composition
US6126832A (en) * 1992-07-30 2000-10-03 Stone; Andrew Composition for dialysis and shock treatment
AU5403494A (en) * 1992-10-16 1994-05-09 Nellson Candies, Inc. Medical food and method of administration
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
EP0700255A4 (en) * 1993-05-26 1997-02-26 Donald Sinclair Hamilton COMPOSITION OF MONOHYDRATE DEXTROSE AND GLUCOSE
US5514656A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Method of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapy
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5668174A (en) * 1993-12-29 1997-09-16 Kowa Tekuno Sachi Co., Ltd. Method of treating hyperparathyroidism
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5700513A (en) * 1996-01-19 1997-12-23 Abbott Laboratories Liquid nutritional product containing improved stabilizer composition
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
US5906978A (en) * 1996-08-14 1999-05-25 Hemocleanse, Inc. Method for iron delivery to a patient by transfer from dialysate
WO1998021953A1 (en) * 1996-11-20 1998-05-28 Crown Laboratories, Inc. Improved liquid nutritional supplement and aseptic process for making same
US6689275B1 (en) 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
JP2001513370A (ja) * 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
US6288116B1 (en) 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
AU6605100A (en) * 1999-06-30 2001-01-31 Ajay Gupta Method and pharmaceutical composition for parenteral administration of iron
US6274169B1 (en) 1999-08-02 2001-08-14 Abbott Laboratories Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
US6051567A (en) * 1999-08-02 2000-04-18 Abbott Laboratories Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
ES2322689T3 (es) * 1999-09-22 2009-06-25 Advanced Renal Technologies Uso de un dializado con elevado contenido de citrato.
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US6995166B1 (en) 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
US7696219B2 (en) * 2000-09-27 2010-04-13 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiences in renal patients
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
CA2439293A1 (en) * 2001-03-05 2002-09-12 Stephen P. Ernest Enteral formulation
US6605310B2 (en) * 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US6660293B2 (en) 2001-06-29 2003-12-09 Everett Laboratories, Inc. Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
DE20215514U1 (de) 2002-10-09 2003-01-02 Bartz, Volker, 35440 Linden Diätetisches Lebensmittel zur Behandlung von Niereninsuffizienz
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US8617617B2 (en) * 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
MXPA05008370A (es) * 2003-01-06 2006-03-13 Nutri Check Technologies Llc Sistema basado en las necesidades de un individuo, para el suministro de complementos.
US20040137080A1 (en) * 2003-01-13 2004-07-15 Cremisi Henry D. Multivitamin regimen for renal patients
GB0306394D0 (en) 2003-03-20 2003-04-23 Univ Nottingham Carnitine retention
EP1646404B1 (en) * 2003-07-11 2010-01-13 AstraZeneca AB Solid composition comprising a proton pump inhibitor
US7067156B1 (en) * 2003-11-10 2006-06-27 Vesselin Danailov Miladinov Dietary supplement for renal dialysis patients
US20080063730A9 (en) * 2004-07-29 2008-03-13 Giordano John A Methods for prophylactic and therapeutic nutritional supplementation
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (en) * 2004-12-30 2007-09-12 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
KR101067266B1 (ko) * 2005-08-29 2011-09-23 아지노모토 가부시키가이샤 영양 조성물
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
JP5527986B2 (ja) * 2008-02-19 2014-06-25 株式会社アーネストメディスン 医薬組成物
KR101325374B1 (ko) * 2008-02-19 2013-11-08 가부시키가이샤 오츠까 세이야꾸 고죠 신체 기능의 회복에 유용한 경구 또는 경장 조성물
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US20140073598A1 (en) * 2012-09-11 2014-03-13 Jaymac Pharmaceuticals Llc Multiple folate formulation and use thereof
MX352660B (es) 2013-03-15 2017-12-04 Univ New York Bebida con contenido de citrato.
US10004762B2 (en) 2013-05-08 2018-06-26 Gambro Lundia Ab Dialysis formulation
EP3200582B1 (en) 2014-09-29 2023-11-15 Fred Hutchinson Cancer Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
IL268883B (en) 2017-03-08 2022-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
EP3723772A4 (en) * 2017-12-11 2021-09-08 Filtricine, Inc. COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR THE TREATMENT OF CANCER AND METABOLIC INTERVENTION THERAPY
WO2020007650A1 (en) * 2018-07-05 2020-01-09 Frieslandcampina Nederland B.V. Protein-rich food bars
CN110897153B (zh) * 2019-11-26 2022-06-10 北京诺葆营养科技有限公司 一种适用于肾病透析患者的营养制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH600787A5 (es) * 1975-03-20 1978-06-30 Nestle Sa
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
CH635351A5 (fr) * 1979-02-09 1983-03-31 Nestle Sa Caseinates d'oligo-elements.
US4419369A (en) * 1980-09-22 1983-12-06 Baylor College Of Medicine Protein mineral dietary module
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
AU577049B2 (en) * 1983-06-16 1988-09-15 Farley Health Products Limited Infant milk formula
GB8507977D0 (en) * 1985-03-27 1985-05-01 Howard Foundation Culinary seasoning compositions
US4880912A (en) * 1987-04-24 1989-11-14 Abbott Laboratories Dispersion and neutralization of acid casein
FR2617016B3 (fr) * 1987-06-26 1989-10-20 Nutribio Sarl Produit destine a completer l'alimentation en micro et macro element
DE4002204A1 (de) * 1990-01-26 1991-08-01 Westfalen Milchwerke Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz

Also Published As

Publication number Publication date
CA2099880A1 (en) 1992-12-11
WO1992022218A1 (en) 1992-12-23
US5108767A (en) 1992-04-28
DE69212316D1 (de) 1996-08-22
EP0587824B1 (en) 1996-07-17
EP0587824A1 (en) 1994-03-23
AU659188B2 (en) 1995-05-11
EP0587824A4 (en) 1994-06-15
HK1004513A1 (en) 1998-11-27
DE69212316T2 (de) 1997-03-06
AU2154292A (en) 1993-01-12
DK0587824T3 (da) 1996-11-25
CA2099880C (en) 2002-11-26
MX9202744A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
ES2092275T3 (es) Producto nutritivo para personas que reciben dialisis renal.
FI971188A0 (fi) Terapeuttinen vitamiini-kalsium yhdistelmä yksikköannoksena galeenisen tabletin muodossa, menetelmä sen valmistamiseksi ja sen käyttö
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
ES2026126T3 (es) Un sistema para la toma, tratamiento y devolucion de sangre de un paciente.
ES2158039T3 (es) Maquina de hemodialisis con valvula de control de tres vias.
ATE9870T1 (de) Fett-emulsion, die ein steroid enthaelt.
ZA888461B (en) Azelastine-containing medicaments for application in the nose and/or at the eye
MX9307883A (es) Aplicacion del riluzol en la preparcion de un medicamento para el tratamiento de lesiones neurologicas.
ATE369752T1 (de) Gelartige nahrungszusammensetzung
ATE135231T1 (de) Verwendung von ''cartilage-inducing factor'' (cif) zur behandlung von hemato- oder lymphopoietischen krankheiten
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
DE68923697D1 (de) Nasale verabreichung von benzodiazepinhypnotika.
ES2189427T3 (es) Productos nutricional para una persona que tiene fallo renal.
DE68924429D1 (de) Diät zur besserem Ueberleben von Kranken mit Sepsis.
AR004486A1 (es) Uso de tripicolinato cromico en la preparacion de un medicamento
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
MY104462A (en) Medical treatment
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
EP0301589A3 (en) Transdermal delivery system
ES2058909T3 (es) Agente para el cuidado de uñas, piel y cabello.
DE59101404D1 (de) Topische Präparate.
ES2133680T3 (es) Metodo continuo para incrementar la concentracion en insolubles en quinolina de alquitran liquido mientras se produce simultaneamente de alquitran exento de insolubles en quinolina.
ES2110104T3 (es) Procedimiento para la administracion de soluciones de factor de estimulacion de las colonias de granulocitos.
EP0261802A3 (en) Perfluoro hexamethyltetramine and synthetic phospholipids, useful in synthetic blood
AR009338A1 (es) Composicion de dosis de unidad multivitaminica y usos de dicha composicion de dosis

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 587824

Country of ref document: ES